IFNGR2 and Dravet syndrome: So, the IFNGR2 rs2834213 G homozygous genotype might tag a genetically determined hyper-responsiveness to type II IFN, which in patients with DS, might be implied in susceptibility to CHDs by influencing crucial regulatory pathways in heart organogenesis.